Detalhe da pesquisa
1.
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
N Engl J Med
; 381(4): 307-316, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31166679
2.
The versatile Kv channels in the nervous system: actions beyond action potentials.
Cell Mol Life Sci
; 77(13): 2473-2482, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31894358
3.
Lipotoxicity in human lung alveolar type 2 A549 cells: Mechanisms and protection by tannic acid.
Chin J Physiol
; 64(6): 289-297, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34975122
4.
A basal level of γ-linolenic acid depletes Ca2+ stores and induces endoplasmic reticulum and oxidative stresses to cause death of breast cancer BT-474 cells.
Chin J Physiol
; 64(4): 202-209, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472451
5.
Intraneural granular cell tumor: Histologic spectrum and histogenetic implication.
J Cutan Pathol
; 47(1): 57-60, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31386226
6.
Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from Asia.
Future Oncol
; 15(28): 3243-3253, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31432689
7.
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
Lancet Oncol
; 19(7): 904-915, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29804902
8.
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer.
Jpn J Clin Oncol
; 48(3): 242-247, 2018 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315394
9.
Voltage-gated K+ channels promote BT-474 breast cancer cell migration.
Chin J Cancer Res
; 30(6): 613-622, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700930
10.
Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway.
Pharmacol Res
; 115: 45-55, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864022
11.
Personalization of loco-regional care for primary breast cancer patients (part 1).
Future Oncol
; 11(9): 1297-300, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25952777
12.
Personalization of loco-regional care for primary breast cancer patients (part 2).
Future Oncol
; 11(9): 1301-5, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25952778
13.
Delayed osseous metastasis from low-grade endometrial stromal sarcoma: Uncommon occurrence deserving recognition.
J Obstet Gynaecol Res
; 41(10): 1669-75, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26171849
14.
Challenges to effective cancer control in China, India, and Russia.
Lancet Oncol
; 15(5): 489-538, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24731404
15.
Bosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.
Oncologist
; 19(4): 346-7, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24674873
16.
Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.
Oncologist
; 19(4): 348-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24674874
17.
From Diversity, Equity, and Inclusion to an Antiracism Strategic Plan: An Academic Department of Psychiatry's Journey.
Psychiatr Serv
; 75(4): 391-394, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347815
18.
Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1.
J Pathol
; 227(3): 357-66, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22407818
19.
Afatinib triggers a Ni2+ -resistant Ca2+ influx pathway in A549 non-small cell lung cancer cells.
Fundam Clin Pharmacol
; 37(2): 253-262, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36191338
20.
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.
Breast Cancer Res Treat
; 136(3): 919-26, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23143284